CMS’ new $50 billion rural health fund seeks to help rural providers sustain care in their communities over the next five ...

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

The expiration of ACA tax credits could drive up premiums across marketplace and commercial insurance plans, a Cigna executive warned.

Marlow Hernandez, the founder and former CEO of Cano Health, was set to face a trial over allegations that he fraudulently enriched himself and his family while managing the senior-focused primary ...

Providers increasingly accuse payers of delaying and denying reimbursement for claims. Now, UnitedHealth Group's Optum subsidiary is hoping to change the dynamic through what they claim is a real-time ...

The Supreme Court has made a series of decisions that have implications for healthcare. Below is an overview of these decisions. The Chevron deference In a 6-3 ruling last week, the Supreme Court ...

Kaiser Permanente announced one of the biggest mergers in recent hospital M&A history on Wednesday. The California-based integrated health system, which owns 39 hospitals, said it plans to acquire ...

Cortica, a provider for children with autism and neurodivergent conditions, last week secured $80 million in funding co-led by Morgan Health and Nexus NeuroTech Ventures. San Diego, California-based ...

The nation’s independent cardiology practices are facing serious challenges, such as financial pressures, rising competition and fragmented technology. These struggles have left many practices with no ...

The use of AI in healthcare has evolved quite a bit over the past few years — with many healthcare organizations transitioning from a state of cautious experimentation to more serious attempts at ...

The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary disease ...

Syndax Pharmaceuticals has won FDA approval for a drug addressing advanced cases of acute leukemia carrying a particular genetic signature that leads to an aggressive form of the disease. The ...